| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |